why choose us

Clinical Trials Search

Showing 20,860 of 132,963 result(s)
Pregabalin for Central Sensitization in TKA

Status: Completed

Condition: Osteo Arthritis Knee

Interventions: participants will receive pregabalin orally 75mg twice daily x 7 days prior to surgery, then 150mg twice daily x 7 days after surgery, followed by 75m

Date: 2022-07-13

Endoscopic Combined Intrarenal Surgery Versus Multi-Tract Percutaneous Nephrolithotomy for Complex Renal Stones:

Status: Completed

Condition: Stone, Kidney

Interventions: In lithotomy position, ureteric catheter will be inserted allowing injection of contrast to obtain a pyelogram.
Shifting the patients in prone po

Date: 2022-07-13

MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy

Status: Completed

Condition: Prostate Cancer

Interventions: Patients will be evaluated with multiparametric MRI prostate followed by ExactVu micro-ultrasound to identify target lesions all of which will be biop

Date: 2022-07-13

Liquid Biopsy for Early Non-small Lung Cancer Detection

Status: Completed

Condition: Non Small-cell Lung Cancer

Interventions: 10 cc of blood is collected at one time point, which is prior to biopsy procedure

Date: 2022-07-13

Investigating Development of Autoimmunity in Post-Acute COVID-19 Syndrome (PACS)

Status: Completed

Condition: COVID-19 Pandemic

Interventions:

Date: 2022-07-13

Function and Scar in Trigger Finger Release

Status: COMPLETED

Condition: Trigger Finger

Interventions: At the level of the A1 pulley, a transverse incision will be made and the flexor pulley will be exposed with blunt dissection.
The pulley will be

Date: 2022-07-13

EZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Status: NOT_YET_RECRUITING

Condition: Non Small Cell Lung Cancer

Interventions: combination of oral tazemetostat and intravenous pembrolizumab treatment for patients with advanced non-small cell lung cancer

Date: 2022-07-13

A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer)

Status: Completed

Condition: Squamous Cell Carcinoma of the Head and Neck

Interventions: Atezolizumab will be administered intravenously at a fixed dose of 1200 mg on Day 1 of each 21-day cycle.

Date: 2022-07-12

Intra-arterial Perfusion in Interventional Radiology

Status: Completed

Condition: Hepatocellular Carcinoma

Interventions: All patients will undergo standard of care locoregional intra-arterial (IA) treatment for HCC.
The procedure will take place utilizing fluoroscop

Date: 2022-07-12